9885 — YSB Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual income statement for YSB, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,065	10,094	14,275	16,972	17,904
Cost of Revenue
Gross Profit	609	914	1,435	1,741	1,813
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	6,631	10,588	15,761	20,172	17,878
Operating Profit	-566	-495	-1,487	-3,200	25.7
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-576	-503	-1,497	-3,210	14.4
Provision for Income Taxes
Net Income After Taxes	-572	-502	-1,500	-3,207	15.1
Minority Interest
Net Income Before Extraordinary Items
Net Income	-572	-494	-1,489	-3,189	30
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-572	-494	-1,489	-3,189	30
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.903	-0.777	-2.32	-8.18	0.048
Dividends per Share